Expression of Somatostatin Receptor (SSTR) Subtypes (SSTR-1, 2A, 3, 4 and 5) in Neuroendocrine Tumors Using Real-time RT-PCR Method and Immunohistochemistry

Molecule targeting therapy using somatostatin (SS) analogues has become a widely accepted modality to treat neuroendocrine tumors (NETs), particularly gastrointestinal (GI) and pancreatic endocrine tumors. On the other hand, little is known about the expression of somatostatin receptor (SSTR) subtyp...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mizutani, Gou, Nakanishi, Yoko, Watanabe, Noriko, Honma, Taku, Obana, Yukari, Seki, Toshimi, Ohni, Sumie, Nemoto, Norimichi
Formato: Artigo
Idioma:Inglês
Publicado: Japan Society of Histochemistry and Cytochemistry 2012
Assuntos:
Regular Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3395302/
https://ncbi.nlm.nih.gov/pubmed/22829710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1267/ahc.12006
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares